Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Pharmacological management of seizures post traumatic brain injury (MAST)
2020-000282-16Phase 3
- Sponsor
- Cambridge University Hospitals NHS Foundation Trust
- Start
- Oct 2020
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3 trial of levetiracetam and phenytoin in post-traumatic epilepsy (PTE) and seizure disorder (2 arms), sponsored by Cambridge University Hospitals NHS Foundation Trust.
02
Drugs
levetiracetamphenytoin
03
Conditions
post-traumatic epilepsy (PTE)seizure disorder
Beyond the preview
Go deeper on 2020-000282-16.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2020-000282-16.